Overall, these results suggested a dysregulated expression of several Nrf2 and AMPK pathway genes in NAFLD patients’ tissue indicating that both the endogenous anti-oxidant/detoxifying system and the AMPK-related energy homeostasis are altered in NAFLD patients and could represent possible targets for treatment. Here, NFE2L2 is linked to metabolic dysfunction-associated steatotic liver disease.